Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.

Main|Search|PHGKB




Last Posted: May 10, 2018

---

• Pharmacogenomic biomarkers: Interpretation of information included in United States and Japanese drug labels.  
  Shimazawa R et al. Journal of clinical pharmacy and therapeutics 2018 May
• Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences.  
  Sivadas Ambily et al. The pharmacogenomics journal 2018 May
• Consensus molecular subtypes classification of colorectal cancer as a predictive factor for chemotherapeutic efficacy against metastatic colorectal cancer.  
  Okita Akira, et al. Oncotarget 2018 4 (27) 18698-18711
• Effect of abcb1 c3435t polymorphism on pharmacokinetics of antipsychotics and antidepressants.  
  Saiz-Rodríguez Miriam, et al. Basic & clinical pharmacology & toxicology 2018 5
• Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome.  
  Jiménez-Jiménez Félix Javier, et al. The pharmacogenomics journal 2018 5
• Hemoglobin level and XRCC1 polymorphisms to select patients with locally advanced rectal cancer candidate for neoadjuvant chemoradiotherapy with concurrent capecitabine and a platinum salt.  
  Formica Vincenzo, et al. Medical oncology (Northwood, London, England) 2018 5 (6) 83

more